137 related articles for article (PubMed ID: 35666302)
1. Long-term opioid use in patients treated with head and neck intensity-modulated radiotherapy.
Zhao L; Moon DH; Avkshtol V; Siropaides CH; Terauchi S; Day AT; Sumer BD; Hughes R; Sher DJ
Support Care Cancer; 2022 Sep; 30(9):7517-7525. PubMed ID: 35666302
[TBL] [Abstract][Full Text] [Related]
2. Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.
Smith WH; Luskin I; Resende Salgado L; Scarborough BM; Lin JY; Özbek U; Miles BA; Gupta V; Bakst RL
Oral Oncol; 2019 May; 92():1-5. PubMed ID: 31010616
[TBL] [Abstract][Full Text] [Related]
3. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
McDonald MW; Liu Y; Moore MG; Johnstone PA
Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancer.
Chen AM; Farwell DG; Luu Q; Vazquez EG; Lau DH; Purdy JA
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):170-5. PubMed ID: 22300572
[TBL] [Abstract][Full Text] [Related]
5. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
[TBL] [Abstract][Full Text] [Related]
7. Opioid use patterns in patients with head and neck cancer receiving radiation therapy: Single-institution retrospective analysis characterizing patients who did not require opioid therapy.
Rich BJ; Schumacher LD; Sargi ZB; Masforroll M; Kwon D; Zhao W; Rueda-Lara MA; Freedman LM; Elsayyad N; Samuels SE; Abramowitz MC; Samuels MA
Head Neck; 2021 Oct; 43(10):2973-2984. PubMed ID: 34143542
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Predictors of Persistent Opioid Use in Survivors of Head and Neck Cancer Treated With Curative Radiation.
Ganju R; Neeranjun R; Morse R; Lominska C; TenNapel M; Chen AM
Am J Clin Oncol; 2022 Apr; 45(4):161-167. PubMed ID: 35131971
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Opioid Use in Post-Surgical Management of Patients With Head and Neck Cancer.
Wang JJ; Rubin SJ; Devaiah AK; Faden DL; Salama AR; Edwards HA
Ann Otol Rhinol Laryngol; 2022 Aug; 131(8):844-850. PubMed ID: 34521247
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.
Gilley DR; Clark AD; Wieser ME; Bollig CA; Dooley LM; Biedermann GB
Head Neck; 2022 Jun; 44(6):1368-1376. PubMed ID: 35315549
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
[TBL] [Abstract][Full Text] [Related]
12. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
13. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
[TBL] [Abstract][Full Text] [Related]
14. Long-term opioid use in curative-intent radiotherapy: One-Year outcomes in head/neck cancer patients.
Schumacher LD; Sargi ZB; Masforroll M; Kwon D; Zhao W; Rueda-Lara MA; Freedman LM; Elsayyad N; Samuels SE; Abramowitz MC; Samuels MA
Head Neck; 2020 Apr; 42(4):608-624. PubMed ID: 31785054
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
Chen AM; Daly ME; Cui J; Mathai M; Benedict S; Purdy JA
Head Neck; 2014 Nov; 36(11):1541-6. PubMed ID: 23996502
[TBL] [Abstract][Full Text] [Related]
16. Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial.
Zayed S; Lang P; Mendez LC; Read N; Sathya J; Venkatesan V; Moulin DE; Warner A; Palma DA
BMC Palliat Care; 2021 Mar; 20(1):45. PubMed ID: 33740977
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of high-dose opioid use among survivors of head and neck cancer.
Nugent SM; Slatore CG; Winchell K; Handley R; Clayburgh D; Chandra R; Hooker ER; Knight SJ; Morasco BJ
Head Neck; 2023 Aug; 45(8):2058-2067. PubMed ID: 37366072
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer.
Ooishi M; Motegi A; Kawashima M; Arahira S; Zenda S; Nakamura N; Ariji T; Tokumaru S; Sakuraba M; Tahara M; Hayashi R; Akimoto T
Jpn J Clin Oncol; 2016 Oct; 46(10):919-927. PubMed ID: 27511989
[TBL] [Abstract][Full Text] [Related]
19. A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT-SIB) in Head and Neck Squamous Cell Cancers.
Ghosh A; Gupta S; Johny D; Vidyadhar Bhosale V; Pal Singh Negi M
Cancer Med; 2021 Aug; 10(15):5175-5190. PubMed ID: 34159749
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
